Clinical Trials Browser

Phase 2/3 × Leukemia, Myelogenous, Chronic, BCR-ABL Positive × Melphalan × Clear all

NCT02707393 2021-04-15

Allogeneic Stem Cell Transplantation for Children With CML

Phase 2/3 Completed

MyeloidOther hematologic neoplasm

Leukemia, Myelogenous, Chronic, BCR-ABL Positive